For research use only. Not for therapeutic Use.
THPP-11f（Cat No.:I037257）is an experimental compound studied for its potential therapeutic applications, particularly in the field of oncology. It is a selective inhibitor that targets specific molecular pathways involved in cancer cell proliferation, survival, and metastasis. THPP-11f has demonstrated activity in preclinical models by inhibiting key enzymes or proteins involved in tumor growth, with a focus on improving treatment outcomes in cancers resistant to conventional therapies. Ongoing research aims to evaluate its safety, efficacy, and pharmacokinetics in clinical trials, potentially offering a new approach for targeted cancer therapies.
| Catalog Number | I037257 |
| Synonyms | THPP-11f; THPP 11f; THPP11f |
| Molecular Formula | C25H31N7O |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 4-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]-N-(1-methylpiperidin-4-yl)pyridin-2-amine |
| InChI | InChI=1S/C25H31N7O/c1-17-12-20(14-27-25(17)33-3)32-11-7-22-21(15-32)24(29-16-28-22)18-4-8-26-23(13-18)30-19-5-9-31(2)10-6-19/h4,8,12-14,16,19H,5-7,9-11,15H2,1-3H3,(H,26,30) |
| InChIKey | MGGGINLIPISYAS-UHFFFAOYSA-N |
| SMILES | CC1=CC(=CN=C1OC)N2CCC3=C(C2)C(=NC=N3)C4=CC(=NC=C4)NC5CCN(CC5)C |
